Cashu | Summary

DJI

+1.00%

SPX

+0.52%

IXIC

+0.52%

FTSE

+0.72%

N225

+1.43%

AXJO

-0.43%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+1.00%

SPX

+0.52%

IXIC

+0.52%

FTSE

+0.72%

N225

+1.43%

AXJO

-0.43%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

4.64M

Dividend Yield

0.00%

P/E Ratio

-1.34

EPS

-2.42

Revenue

13.97M

Avg. Volume

151.00K

About

What does SNOA do?

Sonoma Pharmaceuticals, headquartered in Boulder, Colorado, develops hypochlorous acid products for various healthcare applications and went public on January 26, 2007. Their product lineup includes Lumacyn, Regenacyn, and MicrocynAH for skin and wound care.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

California, USA

Website

http://www.sonomapharma.com